Last year, Insmed Inc generated 433.76M USD for its biggest-performing segment, Arikayce. The US made the largest contribution, accounting for 452.95M USD last year. For the latest quarter, Insmed Inc reported the revenue of 144.61M USD for the period ending 2025-12-31, which came from the top-performing segment, Brinsupri. US contributed the highest revenue, at 378.74M USD.

By Business

Revenue

Proportion

Annual

Annual

Quarterly

Arikayce

Brinsupri

FY2025

Arikayce

433.76M(71.53%)

Brinsupri

172.66M(28.47%)

By Region

Revenue

Proportion

Annual

Annual

Quarterly

International

Japan

Europe and rest of worldld

FY2025

FY2024

FY2023

FY2022

452.95M(74.69%)

254.80M(53.91%)

224.19M(73.46%)

185.99M(75.81%)

International

153.47M(25.31%)

108.91M(23.04%)

--(--)

Japan

--(--)

87.70M(18.56%)

65.73M(21.54%)

56.51M(23.03%)

Europe and rest of worldld

--(--)

21.21M(4.49%)

15.28M(5.01%)

2.86M(1.16%)